Electrophysiological effects of intravitreal Avastin (bevacizumab) in the treatment of exudative age-related macular degeneration.

Karanjia, R; Eng, K T; Gale, J; Sharma, S; ten Hove, M W

Karanjia, R; Eng, K T; Gale, J; Sharma, S; ten Hove, M W.

Affiliation

Karanjia R; Department of Ophthalmology, Queen's University, Hotel Dieu Hospital, 166 Brock Street, Kingston, ON, Canada, K7L 5G2; tenhove@queensu.ca.

Br J Ophthalmol ; 92(9): 1248-52, 2008 Sep.

Article in En | MEDLINE | ID: mdl-18617547

Subject(s)

Angiogenesis Inhibitors/administration & dosage; Antibodies, Monoclonal/administration & dosage; Electroretinography/drug effects; Macular Degeneration/drug therapy; Visual Acuity/drug effects; Aged; Aged, 80 and over; Analysis of Variance; Antibodies, Monoclonal, Humanized; Bevacizumab; Electrophysiology; Female; Humans; Male; Middle Aged; Sensitivity and Specificity; Treatment Outcome; Visual Acuity/physiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Visual Acuity / Angiogenesis Inhibitors / Electroretinography / Macular Degeneration / Antibodies, Monoclonal Type of study: Diagnostic_studies / Evaluation_studies Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Br J Ophthalmol Year: 2008 Document type: Article Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google